According to Nova one advisor, the global Ocular Trauma Devices market was valued at USD 4.18 billion in 2021 and it is expected to hit around USD 7.56 billion by 2030 with a CAGR of 8.2% during the forecast period 2022 to 2030.
Key Takeaways:
Ocular trauma is sometimes referred to as non-penetrating trauma or blunt force trauma to the eye area. Combinations of forces, including acceleration and deceleration, shearing, and crushing pressure can result in ocular trauma. Ocular trauma can cause damage to the eye, the eyelid, and the surrounding bones resulting in blunt eye injuries such as globe exploding, retinal separation, hyphemia, frontal eye hemorrhage, retrobulbar hemorrhage, fracture of the orbit, accidental glaucoma, vitreous bleeding, corneal injuries, and cataract. According to a report by the vision center, around 95% of ocular trauma occurs in men under the age of 30, often caused by interpersonal violence.
Healthcare delivery was severely damaged due to the COVID-19 pandemic. Despite an overwhelming number of COVID-19 cases, ophthalmic clinics witnessed a sharp reduction in outpatient visits and operations, and hospitals lost a large amount of revenue in the initial stage of the pandemic. The COVID-19 pandemic had a negative effect on the sales of ocular devices such as contact lenses, implants, and ocular instruments. Ophthalmic clinics stayed closed throughout the lockdown period since ophthalmologists and healthcare professionals faced the biggest risk of spreading the virus. As a result, there was a decrease in the demand for ocular care products. However, the market is expected to regain its pre-pandemic position in the coming years due to the relaxation of regulations at present and the considerable economic recovery.
Several organizations along with ophthalmologists have launched campaigns and initiatives to increase awareness about ocular care and eye health among the general public. These organizations provide seminars, tutorials, and workshops that teach technicians how to utilize different pieces of ophthalmic equipment. Such programs aid in raising awareness of eye conditions and the availability of diagnostic tools.
Report Scope of the Ocular Trauma Devices Market
Report Coverage |
Details |
Market Size |
USD 7.56 Billion by 2030 |
Growth Rate |
CAGR of 8.2% from 2022 to 2030 |
Largest Market |
North America |
Fastest Growing Market |
Asia Pacific |
Base Year |
2021 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Device type, indication, end-use, and Region, |
Companies Mentioned |
|
Device Type Insights
Based on device type, the market is segmented into implants, instruments, and disposables. Among these, the implants segment accounted for the largest market share of 46.0% in 2021 and is expected to witness the fastest CAGR of 9.0% over the forecast period from 2022 to 2030. The rising incidence of eye-related disorders & injuries such as age-related macular degeneration, cataract, glaucoma, and scleritis is expected to contribute to the growing demand for ocular trauma devices.
The International Diabetes Federation estimates that 643 million people will have diabetes by 2030, up from an estimated 537 million in 2021. The rising prevalence of diabetes across the globe and the growing adoption of a sedentary lifestyle is likely to increase the risk of diabetic retinopathy in the coming years. The rising cases of diabetic retinopathy are likely to increase the demand for ocular trauma devices such as implants and disposables.
Indication Insights
Based on the indication, the market is segmented into blunt trauma, chemical trauma, and sharp trauma. The blunt trauma segment dominated the market with a revenue share of 48.5% in 2021. Combinations of forces such as acceleration and deceleration, shearing, & crushing pressure can result in blunt trauma to the eye area. Blunt eye injury describes an injury or a wound in the vicinity of the eye brought on by a strong blow or a physical assault with a dull instrument. The WHO projects that there will be over 2 billion elderly people worldwide by 2050. The rising elderly population will fuel the expansion of the segment growth across the globe.
On the other hand, the sharp trauma segment is expected to witness the fastest growth during the forecast period with a CAGR of 9.7% owing to the growing cases of sharp object eye injuries, especially in the workplace environment. According to the U.S. Bureau of labor safety, the majority of occupational injuries in the U.S. are caused due to sharp objects, slips, trips, falls, and contact with sharp items & equipment.
End-Use Insights
Based on end-use, the market is segmented into hospitals, ophthalmic clinics, and others. Among these, the hospital segment dominated the market in terms of revenue share in 2021 with a share of 51.2% owing to the growing use of ophthalmic technology and the availability of affordable and efficient treatment in the hospitals. In the upcoming years, the need for new device installations is projected to increase due to the rising number of collaborations between ophthalmic clinics and hospitals due to more patients choosing to have ocular procedures performed in hospitals instead of clinics.
The ophthalmic clinics segment is expected to witness the fastest growth during the forecast period with a CAGR of 8.9% from 2022 to 2030. Due to the increasing need for eye care services in outlying locations, the ophthalmic clinic segment is anticipated to expand significantly over the forecast period. With a sharp increase in the number of specialty ophthalmic centers, it is projected that the growing number of ophthalmologists in developing economies will have a significant impact on segment growth.
Regional Insights
In 2021, North America accounted for the largest revenue share of 44.8% due to the rise in the elderly population, increased cases of eye-related problems, and an overall increase in healthcare costs. Moreover, factors such as high levels of stress, poor lifestyles, and the increased frequency of chronic eye disorders such as diabetic retinopathy are contributing to market growth.
Asia Pacific is anticipated to witness rapid growth over the forecast period with a CAGR of 9.9% pertaining to the significant rise in the aging population along with the improving healthcare infrastructure. In addition, developing nations such as China and India are expected to have the highest development in healthcare delivery. The market in this region is expanding due to the rising diabetic population, growing cataract procedures, and the rising costs of both private & public eye care.
Some of the prominent players in the Ocular Trauma Devices Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Ocular Trauma Devices market
By Geography
Key Benefits for Stakeholders
Chapter 1. Introduction
1.1 Market Segmentation & Scope
1.2 Regional Scope
1.2.1 Estimates And Forecast Timeline
1.3 Objectives
1.3.1 Objective - 1
1.3.2 Objective - 2
1.3.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 Nova one advisor’s Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.3 Information Or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.5.2 Volume Price Analysis (Model 2)
2.6 List Of Secondary Sources
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Device Type
3.2.2 Indication
3.2.3 End Use
3.2.4 Region
3.3 Competitive Insights
3.4 Ocular Trauma Devices Market Outlook, 2021
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Ancillary Market Outlook:
4.2 Ocular Trauma Devices Market Dynamics
4.2.1 Market Driver Analysis
4.2.2 Market Restraint Analysis
4.3 Ocular Trauma Devices Market: Business Environment Analysis Tools
4.3.1 Porter’s Five Forces Analysis
4.3.1.1 Threat Of New Entrants
4.3.1.2 Competitive Rivalry
4.3.1.3 Threat Of Substitutes
4.3.1.4 Bargaining Power Of Buyers
4.3.1.5 Bargaining Power Of Suppliers
4.3.2 Pestel Analysis
4.3.2.1 Political & Legal
4.3.2.2 Economic & Social
4.3.2.3 Technological
4.4 Penetration & Growth Prospect Mapping
4.5 Regulatory Framework
4.6 Impact Of Covid-19 On Ocular Trauma Devices Market
Chapter 5 Ocular Trauma Devices Market: Device Type Analysis
5.1 Ocular Trauma Device Type Market Share Analysis, 2021 & 2030
5.2 Ocular Trauma Device Type Market: Segment Dashboard
5.3 Market Size & Forecasts And Trend Analysis, 2017 To 2030 For The Device Type Segment
5.3.1 Implants
5.3.1.1 Implants Market, 2017 - 2030
5.3.1.2 Instruments
5.3.1.3 Instruments Market, 2017 - 2030
5.3.2 Disposables
5.3.2.1 Disposables Market, 2017 - 2030
Chapter 6 Ocular Trauma Devices Market: Indication Analysis
6.1 Ocular Trauma Indication Market Share Analysis, 2021 & 2030
6.2 Ocular Trauma Indication Market: Segment Dashboard
6.3 Market Size & Forecasts And Trend Analyses, 2017 To 2030 For The Indication Segment
6.3.1 Blunt Trauma
6.3.1.1 Blunt Trauma Market, 2017 - 2030
6.3.2 Chemical Trauma
6.3.2.1 Chemical Trauma Market, 2017 - 2030
6.3.3 Sharp Trauma
6.3.3.1 Sharp Trauma Market, 2017 - 2030
Chapter 7 Ocular Trauma Devices Market: End-Use Analysis
7.1 Ocular Trauma Devices End Use Market Share Analysis, 2021 & 2030
7.2 Ocular Trauma Devices End-Use Market: Segment Dashboard
7.3 Market Size & Forecasts And Trend Analyses, 2017 To 2030 For The End-Use Segment
7.3.1 Hospitals
7.3.1.1 Hospitals Market, 2017 - 2030
7.3.2 Ophthalmic Clinics
7.3.2.1 Ophthalmic Clinics Market, 2017 - 2030
7.3.3 Others
7.3.3.1 Others Market, 2017 - 2030
Chapter 8 Ocular Trauma Devices Market: Regional Analysis
8.1 Ocular Trauma Devices Regional Market Share Analysis, 2021 & 2030
8.2 Regional Market Snapshot
8.3 North America
8.3.1 North America Ocular Trauma Devices Market, 2017 - 2030
8.3.2 U.S.
8.3.2.1 U.S. Ocular Trauma Devices Market, 2017 - 2030
8.3.3 Canada
8.3.3.1 Canada Ocular Trauma Devices Market, 2017 - 2030
8.4 Europe
8.4.1 Europe Ocular Trauma Devices Market, 2017 - 2030
8.4.2 U.K.
8.4.2.1 U.K. Ocular Trauma Devices Market, 2017 - 2030
8.4.3 Germany
8.4.3.1 Germany Ocular Trauma Devices Market, 2017 - 2030
8.4.4 France
8.4.4.1 France Ocular Trauma Devices Market, 2017 - 2030
8.4.5 Italy
8.4.5.1 Italy Ocular Trauma Devices Market, 2017 - 2030
8.4.6 Spain
8.4.6.1 Spain Ocular Trauma Devices Market, 2017 - 2030
8.4.7 Russia
8.4.7.1 Russia Ocular Trauma Devices Market, 2017 - 2030
8.5 Asia Pacific
8.5.1 Asia Pacific Ocular Trauma Devices Market, 2017 - 2030
8.5.2 Japan
8.5.2.1 Japan Ocular Trauma Devices Market, 2017 - 2030
8.5.3 China
8.5.3.1 China Ocular Trauma Devices Market, 2017 - 2030
8.5.4 India
8.5.4.1 India Ocular Trauma Devices Market, 2017 - 2030
8.5.5 Australia
8.5.5.1 Australia Ocular Trauma Devices Market, 2017 - 2030
8.5.6 South Korea
8.5.6.1 South Korea Ocular Trauma Devices Market, 2017 - 2030
8.5.7 Singapore
8.5.7.1 Singapore Ocular Trauma Devices Market, 2017 - 2030
8.6 Latin America
8.6.1 Latin America Ocular Trauma Devices Market, 2017 - 2030
8.6.2 Brazil
8.6.2.1 Brazil Ocular Trauma Devices Market, 2017 - 2030
8.6.3 Mexico
8.6.3.1 Mexico Ocular Trauma Devices Market, 2017 - 2030
8.6.4 Argentina
8.6.4.1 Argentina Ocular Trauma Devices Market, 2017 - 2030
8.6.5 Columbia
8.6.5.1 Columbia Ocular Trauma Devices Market, 2017 - 2030
8.7 Middle East And Africa (MEA)
8.7.1 Mea Ocular Trauma Devices Market, 2017 – 2030
8.7.2 South Africa
8.7.2.1 South Africa Ocular Trauma Devices Market, 2017 - 2030
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia Ocular Trauma Devices Market, 2017 - 2030
8.7.4 Uae
8.7.4.1 Uae Ocular Trauma Devices Market, 2017 - 2030
8.7.5 Israel
8.7.5.1 Israel Ocular Trauma Devices Market, 2017 - 2030
Chapter 9 Competitive Analysis
9.1 Recent Developments & Impact Analysis, By Key Market Participants
9.2 Company Profiles
9.3 ALCON
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 BAUSCH & LOMB, INC.
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 CARL ZEISS AG
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 JOHNSON & JOHNSON VISION
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 COOPERVISION
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 TOPCON
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 ESSILORLUXOTTICA
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 HOYA CORPORATION
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.11 GLAUKOS CORPORATION
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives